Document is current
Any future updates will be listed below
-
Authors
Pourdowlat, Guitti
Mousavinasab, Seyed Ruhollah
Farzanegan, Behrooz
Kashefizadeh, Alireza
Meybodi, Zohreh Akhoundi
Jafarzadeh, Maedeh
Baniasadi, Shadi https://orcid.org/0000-0003-0501-3831
-
Funding
Funding for this research was provided by:
National Research Institute of Tuberculosis and Lung Diseases
- License Information
-
More Information
Article History
Received: 5 January 2021
Accepted: 7 January 2021
First Online: 18 January 2021
Ethics approval and consent to participate
: The current trial was approved by the Ethics Committee of the National Research Institute of Tuberculosis and Lung Diseases (NRITLD) on July 27, 2020. The ethics committee reference number is IR.SBMU.NRITLD.REC.1399.148. We certify that this trial has received ethical approval from the appropriate ethical committee as described above. Informed consent will be obtained from all participants (or their legally authorized representatives) before participation in the trial.
: Not applicable.
: There are no competing interests to be declared.
